Kits Eyecare Ltd (OTCPK:KTYCF)
$ 10.14 +0.29 (+2.94%) Market Cap: 345.66 Mil Enterprise Value: 329.79 Mil PE Ratio: 129.55 PB Ratio: 6.93 GF Score: 73/100

Q4 2024 Kits Eyecare Ltd Earnings Call Transcript

Mar 05, 2025 / 02:00PM GMT
Release Date Price: $6.34 (+5.66%)

Key Points

Positve
  • Kits Eyecare Ltd (KTYCF) achieved a record-breaking revenue of $44.8 million in Q4 2024, representing a 42% organic year-over-year growth.
  • The company reported a full-year revenue of $159.3 million, up 32% from the previous year, with a significant increase in adjusted EBITDA by 182% to $6.4 million.
  • Kits Eyecare Ltd (KTYCF) has maintained nine consecutive quarters of positive adjusted EBITDA, showcasing consistent financial performance.
  • The company expanded its product lineup significantly, introducing over 7,500 eyewear styles and launching new products like smart glasses and tailored collections.
  • Customer loyalty is strong, with 63% of Q4 revenue coming from existing customers, and the company welcomed 79,000 new customers in the quarter.
Negative
  • Despite strong growth, the company faces intensifying competition and pricing pressure in the industry, which could impact future margins.
  • Marketing expenses increased to 14.6% of revenue in Q4, reflecting the high costs associated with customer acquisition and brand awareness campaigns.
  • The company is not anticipating any immediate impact from tariffs but remains vigilant about potential supply chain disruptions.
  • Kits Eyecare Ltd (KTYCF) has not disclosed specific financial targets for its AI initiatives, leaving uncertainty about the expected cost savings.
  • The company has not yet reached a significant market share with its Kits branded contact lenses, which remain a small part of the business.
Operator

Good morning and welcome to the Kits Eyecare fourth-quarter 2024 earnings results conference call. This call is being recorded and available later today for replay.

Your hosts today are Roger Hardy, Chief Executive Officer and Co-Founder of Kits Eyecare; Joseph Thompson, Chief Operating Officer; and Zhe Choo, Chief Financial Officer.

Before we begin, I'm required to provide the following statement respecting forward-looking information which is made on behalf of Kits and all of its representatives on this call. Certain statements made on this call will contain forward-looking information. These forward-looking statements generally can be identified by the use of words such as intend, believe, could, expect, estimate, forecast, may, would, and other words of similar meaning.

This forward-looking information is based on management's opinions, estimates, and assumptions in the light of their experience and perception of historical trends, current conditions, and expected future developments, as well as factors that they currently believe are appropriate and reasonable in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot